Oncotelic Therapeutics, Inc. (OTLC)

OTCMKTS: OTLC · Delayed Price · USD
0.0354
-0.0006 (-1.64%)
Mar 28, 2024, 3:10 PM EDT - Market open

Oncotelic Therapeutics Market Cap

Oncotelic Therapeutics has a market cap or net worth of $14.36 million as of March 28, 2024. Its market cap has decreased by -46.01% in one year.

Market Cap
14.36M
Enterprise Value
26.48M
1-Year Change
-46.01%
Ranking
n/a
Category
Stock Price
$0.04

Market Cap Chart

Since December 1, 1998, Oncotelic Therapeutics's market cap has decreased from $87.40M to $14.36M, a decrease of -83.57%. That is a compound annual growth rate of -6.98%.

History

DateMarket Cap% Change
Nov 14, 202313.20M-24.57%
Nov 13, 202317.50M62.04%
Nov 10, 202310.80M35.00%
Nov 9, 20238.00M-30.43%
Nov 8, 202311.50M3.60%
Nov 7, 202311.10M-6.72%
Nov 6, 202311.90M-
Nov 3, 202311.90M-
Nov 2, 202311.90M3.48%
Nov 1, 202311.50M-12.21%
Oct 31, 202313.10M6.50%
Oct 30, 202312.30M6.96%
Oct 27, 202311.50M-25.81%
Oct 26, 202315.50M-2.52%
Oct 25, 202315.90M-9.14%
Oct 24, 202317.50M-2.23%
Oct 23, 202317.90M-
Oct 20, 202317.90M2.29%
Oct 19, 202317.50M2.34%
Oct 18, 202317.10M19.58%
Oct 17, 202314.30M20.17%
Oct 16, 202311.90M-11.85%
Oct 13, 202313.50M6.30%
Oct 12, 202312.70M-20.13%
Oct 11, 202315.90M-
View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly 739.87B
Novo Nordisk 574.20B
UnitedHealth Group 454.53B
Johnson & Johnson 380.65B
Merck & Co. 333.68B
AbbVie 320.44B
Thermo Fisher 220.92B
AstraZeneca 210.70B
Market Cap Rankings